Oncolytic Herpes Simplex Virus An Emerging Solution for Glioblastoma Glioblastoma (GBM) is one of the most aggressive and deadliest cancers with only few patients survive 2.5 years and less than 5% of patients survive 5 years following diagnosis 1 ....

Immune Checkpoint Inhibitor Therapy in Patients with Autoimmune Disorders: A Brief Review The clinical development of immune checkpoint inhibitors (ICIs), including those targeting the programmed cell death 1 and its ligand 1 (PD-1/PD-L1), or cytoto...

Advancement in Diagnostic Imaging for Early Detection of Hepatocellular Carcinoma Hepatocellular carcinoma (HCC) is the most common malignant tumour of the liver, whereas patients with HCC are often unaware of its presence until the tumour has progr...

The Applications of Oncolytic Virus in Cancer Therapy The observation of cancer remission after viral infection was reported in the early 1900s, which led to the hypothesis of treatment against cancer with virotherapy. In fact, there were clinical t...